| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |